tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tejas Savant, 85 are a HOLD (35.71%), 12 are a SELL (5.04%), 141 are a BUY (59.24%).
Analyst Tejas Savant, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 34.03% that have a potential upside of 24.17% achieved within 107 days.
Tejas Savant’s has documented 484 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on NTRA, Natera at 05-Mar-2025.
Analyst best performing recommendations are on CTKB (CYTEK BIOSCIENCES).
The best stock recommendation documented was for CTKB (CYTEK BIOSCIENCES) at 2/29/2024. The price target of $9 was fulfilled within 1 day with a profit of $1.3 (16.88%) receiving and performance score of 168.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$3.65 (49.66%)
$7
19 days ago
(20-Feb-2025)
7/12 (58.33%)
$2.63 (31.42%)
100
Hold
$7.5
$0.15 (2.04%)
$5
1 months 11 days ago
(28-Jan-2025)
3/4 (75%)
$-0.35 (-4.46%)
144
Buy
$9
$1.65 (22.45%)
$8
2 months 21 days ago
(18-Dec-2024)
4/8 (50%)
$3.03 (50.75%)
101
Buy
$6
$-1.35 (-18.37%)
$8
7 months 9 days ago
(02-Aug-2024)
2/2 (100%)
$1.7 (39.53%)
222
Hold
$10
$2.65 (36.05%)
$13
1 years 4 months 15 days ago
(24-Oct-2023)
1/6 (16.67%)
$5.31 (113.22%)
5
Which stock is Tejas Savant is most bullish on?
Which stock is Tejas Savant is most reserved on?
What Year was the first public recommendation made by Tejas Savant?
